Science & Research
Nerve Damage Identified as Unexpected Cause of Cancer Immunotherapy Resistance
A multinational research team has discovered that cancer-induced nerve damage contributes to immunotherapy resistance, potentially opening new treatment avenues for patients.
New Particle Discovery Could Overcome Key Quantum Computing Stability Challenge
Researchers have identified a previously overlooked particle that may solve quantum computing's critical stability problems, potentially enabling the development of reliable large-scale quantum machines.
CNS Pharmaceuticals CEO Outlines Glioblastoma Treatment Strategy and Market Opportunities in Podcast Interview
CNS Pharmaceuticals CEO John Climaco discussed the company's progress in developing novel brain cancer treatments and expanding into aggressive cancers like triple-negative breast cancer with brain metastases during a recent BioMedWire podcast appearance.
Soligenix Advances Rare Disease Pipeline with Key Clinical Milestones Expected Through 2026
Soligenix Inc. reports significant progress in its late-stage rare disease treatments, including pivotal Phase 3 cancer trial results due in 2026 and multiple fast-tracked therapies that could transform care for underserved patient populations.
7-HOPE Alliance Defends Legality and Safety of 7-OH, Challenges Kratom Association Claims
The 7-HOPE Alliance asserts that 7-hydroxymitragynine is lawful and scientifically supported, countering claims by kratom associations while highlighting potential medical benefits and harm reduction value.
Cybin Receives Australian Approval for Phase 3 Study of Psychedelic-Based Depression Treatment
Cybin Inc. has secured Australian regulatory approval to conduct its EMBRACE Phase 3 clinical trial of CYB003, a novel deuterated psilocin analog, marking a significant advancement in developing next-generation treatments for major depressive disorder.
NRx Pharmaceuticals' Depression Treatment Receives FDA Fast Track Designation
NRx Pharmaceuticals' NRX-100 received FDA Fast Track designation for treating suicidal ideation, potentially expanding its market to 13 million U.S. adults and offering a novel approach targeting neuroplasticity in depression treatment.
World Heart Federation Honors American Heart Association CEO with Lifetime Achievement Award
Nancy Brown receives global recognition for her transformative leadership in advancing cardiovascular health worldwide through scientific innovation and quality improvement initiatives.
AI Model Predicts EV Battery Degradation, Paving Way for Longer-Lasting and Safer Electric Vehicles
Researchers at Uppsala University have developed an AI tool that accurately maps electric vehicle battery degradation over time, potentially enhancing battery safety and lifespan for companies like Bollinger Innovations, Inc. (NASDAQ: BINI).
Blocking Brain Damage from Glioblastoma May Slow Tumor Growth and Extend Cognitive Function
New research from University College London suggests that preventing brain damage caused by glioblastoma could significantly slow tumor progression and preserve cognitive function longer in patients.
New 'Love Footprint' Metric Aims to Transform Tourism Sustainability Measurement
Researchers introduced a pioneering 'Love Footprint' metric at an international tourism congress, offering a new way to quantify travelers' positive ethical and transformative impacts on destinations alongside traditional carbon measurements.
D-Wave Quantum Advances Cryogenic Packaging to Scale Quantum Processors to 100,000 Qubits
D-Wave Quantum Inc. has launched a strategic initiative to develop advanced cryogenic packaging technology, leveraging NASA JPL expertise to enhance scalability and interconnectivity for both gate-model and annealing quantum processors targeting architectures of up to 100,000 qubits.
Detox Nation's Holistic Approach Addresses Rising Toxic Exposure in Modern Society
Sinclair Kennally's Detox Nation has developed a structured detoxification protocol that addresses the growing cellular toxic load, which has increased from approximately 10 contaminants per cell in 2008 to about 500 in 2018, offering scalable solutions for chronic illness through education and community support.
New Podcast Explores Neuroplastic Pain Affecting 1.5 Billion People Worldwide
Dr. David Clarke's podcast 'The Story Behind the Symptoms' addresses the growing epidemic of neuroplastic pain conditions through patient interviews and evidence-based Neuroplastic Recovery Therapy, offering alternatives to traditional medical treatments.
AI-Human Collaboration Pioneers Emotional Brain Shunting Research
A groundbreaking collaboration between human researchers and AI systems from OpenAI and Google DeepMind is developing the Emotional Brain Shunting framework to study how the brain redirects emotional energy, potentially revolutionizing mental health and resilience science.
Boone Heart Institute to Host Summit Conference 2025 Focused on Preventive Cardiology Advancements
The Boone Heart Institute's Summit Conference 2025 in Denver will bring together healthcare professionals to address atherosclerosis, the world's leading cause of death, through cutting-edge research and clinical innovations in preventive cardiology.
Mitochondrial Therapy Shows Promise in Slowing Aging Effects
A pioneering therapy using placental mitochondria transplantation offers potential to slow or reverse aging by recharging cellular function, representing a significant advancement in treating previously incurable conditions.
Jefferson Lab Implements Workforce Restructuring with Voluntary Resignation Program
The Thomas Jefferson National Accelerator Facility is reducing its workforce by 7% through voluntary resignations as part of a strategic restructuring to enhance research capabilities.
Creative Biolabs Launches Integrated Cell Therapy Platforms to Advance Cancer Immunotherapy
Creative Biolabs has launched fully integrated CAR-T and TIL therapy development platforms, providing researchers and biotech startups with comprehensive services to accelerate the development of next-generation cellular immunotherapies for cancer treatment.
Global Study Reveals Transboundary River Basins Lag Behind in Sustainability Goals
A comprehensive analysis of 310 transboundary river basins worldwide shows they score significantly lower on sustainability metrics than national averages, with coordinated action on clean water, economic growth, and health identified as the most effective path to improvement.
ESGold Corp's ANT Survey Reveals Untapped Mineral Potential at Historic Montauban Mine
ESGold Corp's recent Ambient Noise Tomography survey indicates significant untested mineral structures at the Montauban site, suggesting potential for major district-scale discoveries beyond the original mine operations.
Columbia University Scientists Develop Bacterial Trojan Horse Method to Deliver Anti-Cancer Viruses
Columbia University researchers have engineered bacteria to deliver cancer-killing viruses directly into tumors, bypassing immune system defenses and potentially revolutionizing cancer treatment approaches.
MIT Researchers Develop AI Method to Enhance RNA Nanoparticle Design for Improved Therapeutics
MIT researchers have created an AI-driven approach to optimize RNA nanoparticle design, potentially revolutionizing the delivery of RNA vaccines and treatments while highlighting the growing commercial impact of quantum computing companies like D-Wave.
Sethera Therapeutics Announces Enzymatic Platform for Advanced Peptide Drug Development
Sethera Therapeutics has published research on an enzymatic platform that creates stable peptide structures, potentially enabling more effective and orally deliverable peptide therapeutics.
Mileutis Wins 2025 AgTech Breakthrough Award for Antibiotic-Free Dairy Therapy
Mileutis has received the 2025 AgTech Breakthrough Award for its antibiotic-free biologic therapy IMILAC, which addresses mastitis in dairy cows while combating antimicrobial resistance and improving milk production sustainability.
Vaginal Estrogen Tablets Show No Increased Stroke Risk for Postmenopausal Women with Prior Stroke History
A Danish registry study found vaginal estrogen tablets do not increase recurrent stroke risk in postmenopausal women with prior strokes, offering reassurance for safe symptom management in this high-risk population.
ReAlta Life Sciences Gains EMA Orphan Drug Designation for Graft-Versus-Host Disease Treatment
ReAlta Life Sciences received European Medicines Agency Orphan Drug Designation for its drug pegtarazimod, advancing a novel dual-targeting treatment approach for steroid-refractory acute graft-versus-host disease that addresses critical unmet medical needs.
Entrapeer Launches AI-Powered Tools to Streamline Enterprise Research and Global Collaboration
Entrapeer's new AI-driven features enable enterprises to quickly translate research, generate executive summaries, and create presentations, enhancing cross-border collaboration and strategic decision-making.
Creative Biogene Expands Antibody Purification Platform to Support Biotechnology Innovation
Creative Biogene's enhanced antibody purification platform offers scalable, high-yield purification solutions critical for advancing biotech research and development.
GeoVax Secures Patent for Multi-Antigen COVID-19 Vaccine Technology
GeoVax Labs has obtained a key U.S. patent for its multi-antigen COVID-19 vaccine technology, strengthening its position in developing next-generation vaccines that could provide broader and more durable protection against evolving variants.